CoChat

HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins

Open access
Sun, Lei, Ke, Jia, He, Zhen, Chen, Zexian, Huang, Qinghua, Ai, Wenjia, Wang, Guoqiang, Wei, Yisheng, Zou, Xiangcai, Zhang, Shi, Lan, Ping, Hong, Chuyuan · 2017 · Journal of Cancer
Cited by 91

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Background and Aim: Hairy enhancer of split-1 (HES1) is a downstream transcriptional factor of Notch signaling pathway, which was found to be related to chemoresistance.This study was aimed to investigate the role of HES1 in chemoresistance of colorectal cancer (CRC).Methods: Tissue microarray was used to analyze the clinical significance of HES1 in radical resected (R0) stage II/III CRC patients that received adjuvant chemotherapy.5-fluorouracil (5-Fu) chemoresistance was examined in CRC cell lines (RKO and HCT8, LOVO) with stable over-expression and inhibition of HES1 gene by cytotoxicity test.Gene expression microarray was used to investigate the enriched pathways and different expressed of genes in cells with over-expressed HES1.Expression changes of the chemoresistance related genes were confirmed by qPCR and western blot analysis.Results: Stage II CRC patients with higher HES1 expression showed higher recurrence rate after chemotherapy.Colon cancer cell lines which over-expressed HES1 were more resistant to 5-Fu treatment in vitro.Gene expression microarray revealed that HES1 was related to the signaling pathways of epithelial-mesenchymal transition (EMT) and drug metabolism.Immunofluorescence assay showed HES1 over-expression lead to depressed E-cadherin and elevated N-cadherin.QPCR and western blot analysis confirmed that ABCC1, ABCC2 and P-gp1 were induced after HES1 over-expression.Conclusions: HES1 promotes chemoresistance to 5-Fu by prompting EMT and inducing of several ABC transporter genes.HES1 might be a novel therapeutic target in CRC treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/jca.19142

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 91

Metadata

Authors
Sun, L., Ke, J., He, Z., Chen, Z., Huang, Q., Ai, W., Wang, G., Wei, Y., Zou, X., Zhang, S., Lan, P., & Hong, C.
Venue
Journal of Cancer
Published
2017
Volume
8
Issue
14
Pages
2802-2808
ISSN
1837-9664 (ISSN-L)
OpenAlex
W2756355820
Cited by
91
References
1
FWCI
3.45
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins. https://app.cochat.ai/papers/10.7150/jca.19142
The paper
Sun, L., Ke, J., He, Z., Chen, Z., Huang, Q., Ai, W., Wang, G., Wei, Y., Zou, X., Zhang, S., Lan, P., & Hong, C. (2017). HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins. Journal of Cancer. https://doi.org/10.7150/jca.19142

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.